
Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma
Author(s) -
Dong Liu,
Juan Zhang,
Lilong Wu,
Xiaoming Yang,
Zheng Chen,
Jiangzi Yuan
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s317319
Subject(s) - immune system , breast cancer , oncology , biology , carcinoma , medicine , cancer research , cancer , immunology
Myelin and lymphocyte protein (MAL) plays an essential role in esophageal cancer, classic Hodgkin's lymphoma and breast cancer. However, its role in uterine corpus endometrial carcinoma (UCEC) has not been explored. Therefore, the current study sought to explore the role of MAL in UCEC.